C.M. Bidwell & Associates’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$695 Buy
+50
New +$780 ﹤0.01% 462
2021
Q3
Sell
-2,415
Closed -$50K 561
2021
Q2
$50K Sell
2,415
-1,610
-40% -$31.1K 0.03% 299
2021
Q1
$67K Sell
4,025
-130
-3% -$2.19K 0.05% 274
2020
Q4
$61K Sell
4,155
-14,205
-77% -$180K 0.05% 269
2020
Q3
$188K Sell
18,360
-55
-0.3% -$623 0.17% 121
2020
Q2
$201K Buy
+18,415
New +$190K 0.18% 126

Other funds holding ADTN

C.M. Bidwell & Associates's ADTN Position: Q2 2026 in Review

C.M. Bidwell & Associates opened a new position in Adtran (ADTN) in Q2 2026: 50 shares worth $695. The stake represents ﹤0.01% of the portfolio and ranks #462 among its holdings. This is a return to the name: C.M. Bidwell & Associates previously reported a position in ADTN as recently as Q2 2021.

C.M. Bidwell & Associates first reported a position in ADTN in Q2 2020 and has held it in 6 quarters since. The position peaked at $201K in Q2 2020. 249 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • C.M. Bidwell & Associates held 50 shares of Adtran worth $695 as of Q2 2026.
  • Adtran was a new C.M. Bidwell & Associates position in Q2 2026.
  • Adtran made up ﹤0.01% of C.M. Bidwell & Associates's portfolio in Q2 2026, its #462 holding.
  • C.M. Bidwell & Associates first reported a position in Adtran in Q2 2020 and has held it in 6 quarters since.
  • C.M. Bidwell & Associates's Adtran position peaked at $201K in Q2 2020.
  • 249 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on C.M. Bidwell & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.